Walgaard, C.

patient syndrome study gbs patients weakness admission guillain-barre syndrome guillain –barr syndrome hospital admission score insufficiency guillain-barre cohort model hospital treatment gbs disability score guillain disease outcome neurol trial –barr onset nerve mrc sum score factor disability derivation cohort validation insuf ficiency derivation ivig dose level prognosis neurology course schmitz pi feature validation cohort hughes ra predictor infection insuf erasmu lancet ficiency van doorn pa prognostic 2 weeks 6 months hughe ivig treatment antibody multivariate increase month analysis bulbar cornblath dr ventilation discriminative ability fi rst week effect regression line re flects serum igg level criteria intubation /or bulbar weakness dutch point group doorn care unit 4 weeks scale jacob plasma exchange risk factors